Concepedia

Carlos Herrera-Montávez

CH

7

Publications

271

Citations

7

H-Index

2019

Active since

Affiliations

Fox Chase Cancer Center(Current)

Icahn School of Medicine at Mount Sinai

Carlos Herrera-Montávez is an author at Fox Chase Cancer Center specializing in oncology, medicine, and cell biology.

ORCID

Top concepts

Publications per year

2019–2022

7

Publications

7

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells

Alison Kurimchak, Carlos Herrera-Montávez, Sara Montserrat‐Sangrà et al. · Science Signaling · 2022 · 92 citations · Full text

Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D

Susan Kennedy, Mohamed Ali Jarboui, Sriganesh Srihari et al. · Nature Communications · 2020 · 71 citations · Full text

Intrinsic Resistance to MEK Inhibition through BET Protein–Mediated Kinome Reprogramming in NF1-Deficient Ovarian Cancer

Alison Kurimchak, Claude Shelton, Carlos Herrera-Montávez et al. · Molecular Cancer Research · 2019 · 31 citations · Full text

Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma

Alison Kurimchak, Carlos Herrera-Montávez, Jennifer Brown et al. · Science Signaling · 2020 · 30 citations · Full text

, , +15

Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target

Alison Kurimchak, Vikas Kumar, Carlos Herrera-Montávez et al. · Molecular & Cellular Proteomics · 2020 · 23 citations · Full text

Rows per page

1–5 of 7